Showing results (11-20 of 108) with videos related to
Sort By:
Pageof 11
Japanese Journal of Clinical Oncology|October 6, 2017
Immunochemotherapy using rituximab (RTX) and high-dose methotrexate (HD-MTX): an evaluation of the addition of RTX to HD-MTX in recurrent primary central nervous system lymphoma (PCNSL)Yasuji Miyakita, Makoto Ohno, Masamichi Takahashi, et al.Journal of Lipid Research|November 22, 2015
Identification of amino acid residues that determine the substrate specificity of mammalian membrane-bound front-end fatty acid desaturasesKenshi Watanabe, Makoto Ohno, Masahiro Taguchi, et al.Physiology & Behavior|April 27, 2010
Morinda citrifolia fruit reduces stress-induced impairment of cognitive function accompanied by vasculature improvement in miceJunko Muto, Lee Hosung, Akemi Uwaya, et al.Japanese Journal of Clinical Oncology|July 20, 2022
Continuing maintenance temozolomide therapy beyond 12 cycles confers no clinical benefit over discontinuation at 12 cycles in patients with IDH1/2-wildtype glioblastomaMakoto Ohno, Yasuji Miyakita, Masamichi Takahashi, et al.Neurologia Medico-Chirurgica|October 27, 2011
Reactivation of hepatitis B virus after glioblastoma treatment with temozolomide--case reportMakoto Ohno, Yoshitaka Narita, Yasuji Miyakita, et al.Journal of Neuro-Oncology|October 26, 2013
Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgeryHideyuki Arita, Yoshitaka Narita, Yasuji Miyakita, et al.Behavioural Brain Research|January 23, 2018
Intermittent intense exercise protects against cognitive decline in a similar manner to moderate exercise in chronically stressed miceHyunjin Lee, Kazufumi Nagata, Sanae Nakajima, et al.Japanese Journal of Clinical Oncology|March 5, 2020
Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphomaYasuji Miyakita, Makoto Ohno, Masamichi Takahashi, et al.Japanese Journal of Clinical Oncology|August 2, 2015
Health-related quality of life in long-term survivors with Grade II gliomas: the contribution of disease recurrence and Karnofsky Performance StatusYoshiko Okita, Yoshitaka Narita, Ruriko Miyahara, et al.Asia-Pacific Journal of Clinical Oncology|August 18, 2012
Development of secondary skull sarcoma after treatment for childhood acute myeloid leukemiaMakoto Ohno, Yoshitaka Narita, Yasuji Miyakita, et al.Pageof 11